Monday, August 3, 2009


The Corporate Funded Birth Of Disease Through Unease

Attempts to convince normally healthy people that they are in fact sick and there for require pharmacological intervention can significantly inflate the market specific to the disease state whose boundaries diagnostically are now artificially expanded through disease mongering.

The financial cost to both the individual and the community due to disease mongering is rather high. Deliberate separation from the pharmaceutical industry- as well as a tactical plan for thorough critical analysis- are necessary to combat disease mongering.

Furthermore, educating patients who in fact may not be patients by empowering them to make correct decisions regarding their health are of importance as well.

Disease mongering is medicalization, which is the deliberate marketing plan of turning what are normal and common lifespan events that are far from chronic into fictional medical conditions.

Through propaganda, disease mongering creates the perception among others that occurrences that are within normal limits are in fact concerning symptoms. This leads others to believe that risks are potentially disease states.

This propaganda done by the pharmaceutical industry is performed through public awareness campaigns ad nauseum in mass media with the intent to strongly persuade others to seek and acquire new marketed treatments by this industry.

In addition, the creation of support groups for these disease states that are not are provided by the pharmaceutical industry that are in reality front groups for members of this industry.

Clinical data shared with the public is often fabricated, embellished, or misrepresented. The frequent claim that a drug provides relative risk reduction greatly of a disease state believed to exist is a manipulation by the drug company. Absolute risk reduction, however, is the true representation of the efficacy of a drug.

For example, if drug A states that it provides a 50 percent relative risk reduction in the progression of alopecia often sounds impressive to many. In reality, this may and often means that out of, say, 100 people, two had progressive alopecia. Yet with drug A, only 1 out of 100 had alopecia.

When the ladder, absolute risk reduction, is presented, it gives the impression that drug A really is not that efficacious after all.

The copious amounts of advertising by the pharmaceutical industry is done so with the intent to create fear, anxiety, or sadness upon the viewer about their lack of ideal health that deceptively is far from the truth.

As a society in the U.S., we are falsely led to believe that youth and efficacy as an individual should be acquired at any cost. Any fallacy perceived by one that prevents the acquisition of youth and efficacy ultimately leads many others to eliminate such fallacies.

Examples of diseases simply created by drug companies include erectile dysfunction, which is a symptom often of a truly existing disease, social phobia, which is simply introversion- a normal personality component of humans, as well as male pattern baldness, which occurs naturally in about half of men due to genetic predisposition.

The danger and consequences of disease mongering include the waste of often precious medical resources, as well as the possibly of causing iatrogenic harm to one seeking restoration of their health.

And the pharmaceutical industry has allies with their business plans of disease mongering. These include again front groups, hired journalists, public relations companies hired by drug companies, as well as doctor groups.

All utilize mass media to facilitate their objective. Disease Mongering is more frequent presently due to lifestyle drugs- drugs that do not delay the progression of authentic disease, or treat these diseases, but rather comfort a consumer rather than a patient.

Lawmakers in the United States are aware of disease mongering. However through over saturated lobbying by those in the pharmaceutical industry, such government officials have chosen not to intervene to prevent this potentially dangerous marketing tactic.

This is concerning, considering that presently the restructuring of the health care system in the United States is in its first phase. Disease mongering is not contributing, but in fact is corrupting this restructuring,

Dan Abshear

No comments: